Li, Jing et al
"Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved N-Acetylgalactosamine–Conjugated RNA Interference Therapeutic." Drug Metabolism and Disposition
49.7
(2021):
572-580.
Web. 24 Oct. 2021.
